About Us

Paperplane Therapeutics is at the forefront of developing virtual reality therapies that revolutionize patient care by effectively managing pain and anxiety in healthcare settings.

Specializing in Cognitive-Behavioral Therapies in Virtual Reality Since 2019

Dr. Fortin, an emergency physician, recognized the need for non-pharmacological solutions to enhance patient comfort during medical care. Teaming up with Prof. David Paquin, an expert in immersive technologies, they developed the company's first products. Successful clinical studies confirmed the effectiveness of their virtual reality therapy for managing pain and anxiety in children, leading to the establishment of Paperplane Therapeutics to bring these innovative solutions to market.

Our Offering

Safety and Effectiveness
Rigorous clinical trials and an unwavering dedication to high-quality standards ensure that every solution we provide is not only effective and secure but also deeply valued by our patients. We firmly believe in the transformative power of trust and reliability when it comes to managing pain and anxiety.
Data-Driven Innovation
By harnessing the power of AI, we utilize data to tailor treatments for each individual patient. Through continuous data analysis, we not only enhance our offerings but also ensure they evolve to meet the ever-changing needs of patients.
User-Friendly Solutions for Healthcare Professionals
Our designs emphasize simplicity and efficiency, enabling seamless integration of our treatments into busy workflows. This ensures an elevated standard of patient care without adding to professionals' time burdens.
Accessibility and Affordability for All Ages
Central to our mission is the commitment to make our treatments accessible and affordable for patients of all ages. We are devoted to breaking down barriers to treatment, ensuring that high-quality, non-pharmacological solutions are accessible to everyone, regardless of age or background.

Team

Co-founders & Executives

Dr. Jean-Simon Fortin, M.D.
President (CEO), Co-founder

Dr. Jean-Simon Fortin, M.D.

An emergency physician by training, Jean-Simon Fortin has acted as a consultant for various companies in the medical field for 5 years. His experience in the health sector has shown him that young people are under great stress and experience great anxiety during episodes of care. Thanks to his clinical experience, Jean-Simon Fortin ensures an efficient transfer of Paperplane Therapeutics technological solutions in clinical or hospital settings.

Read Bio
Pr. David Paquin, Ph.D.
Chief Technology Officer (CTO),
Co-founder

Pr. David Paquin, Ph.D.

David Paquin is a full professor and co-founder of the Creation and New Media Department at the University of Quebec in Abitibi-Témiscamingue (UQAT). Specializing in experience design, his research-creation work focuses on the design and development of immersive and interactive devices whose fields of intervention are varied: scientific, experimental or artistic. With twenty years of experience in the design, research and development of video games and virtual reality simulations, David Paquin ensures that the solutions offered by Paperplane Therapeutics are at the cutting edge of technology and adapted to customer needs.

Read Bio
Ian Miller
CRO

Ian Miller

Ian, our Chief Revenue Officer at Paperplane Therapeutics, specializes in scaling businesses, particularly in the dental sector. With a stellar track record, he prioritizes trust-building and innovation. His commitment to exceeding expectations consistently drives remarkable results, solidifying his status as a visionary leader. Ian's diverse background, which includes earning a spot in the Guinness Book of World Records, has enriched him with unparalleled expertise.

Read Bio

Advisory Committee

Pascale Audette
Former CEO at Carebook, Former COO at Behavior Interactive
Laurent D. Ziri
Co-Founder Jenthera Therapeutics, Former CFO of the Montreal Jewish Hospital
Julien Laferrière
Senior Producer at Ubisoft
Howard Fried
Former VP Global Sales & Business Dev at Carebook, Former Global Director at Medtronics
Samuel M. Ohayon
Strategic Advisor